BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25545056)

  • 1. Gene therapy for the eye focus on mutation-independent approaches.
    Dalkara D; Duebel J; Sahel JA
    Curr Opin Neurol; 2015 Feb; 28(1):51-60. PubMed ID: 25545056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.
    Rakoczy EP; Narfström K
    Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery to cone photoreceptors by subretinal injection of rAAV2/6 in the mouse retina.
    Hori T; Fukutome M; Maejima C; Matsushima H; Kobayashi K; Kitazawa S; Kitahara R; Kitano K; Kobayashi K; Moritoh S; Koike C
    Biochem Biophys Res Commun; 2019 Jul; 515(1):222-227. PubMed ID: 31146917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.
    Colella P; Auricchio A
    Hum Gene Ther; 2012 Aug; 23(8):796-807. PubMed ID: 22734691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Update on Gene Therapy for Inherited Retinal Dystrophy: Experience in Leber Congenital Amaurosis Clinical Trials.
    Chiu W; Lin TY; Chang YC; Isahwan-Ahmad Mulyadi Lai H; Lin SC; Ma C; Yarmishyn AA; Lin SC; Chang KJ; Chou YB; Hsu CC; Lin TC; Chen SJ; Chien Y; Yang YP; Hwang DK
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.
    Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A
    Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus-vectored gene therapy for retinal disease.
    Dinculescu A; Glushakova L; Min SH; Hauswirth WW
    Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for inherited retinal degenerations.
    Dalkara D; Sahel JA
    C R Biol; 2014 Mar; 337(3):185-92. PubMed ID: 24702845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation-Independent Gene Therapies for Rod-Cone Dystrophies.
    Fortuny C; Flannery JG
    Adv Exp Med Biol; 2018; 1074():75-81. PubMed ID: 29721930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seeing is believing: gene therapy shows promise for ocular disorders.
    Friedrich MJ
    JAMA; 2010 Oct; 304(14):1543-5. PubMed ID: 20940376
    [No Abstract]   [Full Text] [Related]  

  • 11. AAV-mediated gene therapy for the treatment of retinal diseases.
    Rolling F
    Curr Gene Ther; 2010 Oct; 10(5):318. PubMed ID: 20874705
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of gene therapy on visual function in Leber's congenital amaurosis.
    Bainbridge JW; Smith AJ; Barker SS; Robbie S; Henderson R; Balaggan K; Viswanathan A; Holder GE; Stockman A; Tyler N; Petersen-Jones S; Bhattacharya SS; Thrasher AJ; Fitzke FW; Carter BJ; Rubin GS; Moore AT; Ali RR
    N Engl J Med; 2008 May; 358(21):2231-9. PubMed ID: 18441371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CEP290 C-Terminal Domain Complements the Mutant CEP290 of Rd16 Mice In Trans and Rescues Retinal Degeneration.
    Mookherjee S; Chen HY; Isgrig K; Yu W; Hiriyanna S; Levron R; Li T; Colosi P; Chien W; Swaroop A; Wu Z
    Cell Rep; 2018 Oct; 25(3):611-623.e6. PubMed ID: 30332642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Italian Job: An Interview with Federico Mingozzi.
    Davies K
    Hum Gene Ther; 2020 Oct; 31(19-20):1027-1030. PubMed ID: 33074024
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy reforms photoreceptor structure and restores vision in NPHP5-associated Leber congenital amaurosis.
    Aguirre GD; Cideciyan AV; Dufour VL; Ripolles-García A; Sudharsan R; Swider M; Nikonov R; Iwabe S; Boye SL; Hauswirth WW; Jacobson SG; Beltran WA
    Mol Ther; 2021 Aug; 29(8):2456-2468. PubMed ID: 33781914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration.
    Fuller-Carter PI; Basiri H; Harvey AR; Carvalho LS
    BioDrugs; 2020 Dec; 34(6):763-781. PubMed ID: 33136237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.
    Daich Varela M; Cabral de Guimaraes TA; Georgiou M; Michaelides M
    Br J Ophthalmol; 2022 Apr; 106(4):445-451. PubMed ID: 33712480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular disease.
    Roy K; Stein L; Kaushal S
    Hum Gene Ther; 2010 Aug; 21(8):915-27. PubMed ID: 20384478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent breakthroughs in gene therapy for inherited retinal degeneration.
    Revere KE; Chung DC
    Discov Med; 2009 Oct; 8(42):125-9. PubMed ID: 19833058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.